Cmpx analyst
WebMar 17, 2024 · Most Recent. CMPX Analyst Ratings. Joseph Pantginis, a bottom 7% analyst. from HC Wainwright & Co. reiterates CMPX with a buy rating and maintains their CMPX price target from $10.00 to $10.00, on Mar 16, 2024.. Maury Raycroft, a bottom 14% analyst. from Jefferies initiates coverage on CMPX with a strong buy rating and … WebMar 14, 2024 · NASDAQ: CMPX Last close prices updated as of Mar 14, 2024, 4:00 PM EST USD BATS BZX Real-Time Price Overview Key Ratios Trading Information Last Close 3.6 Sector Healthcare Industry...
Cmpx analyst
Did you know?
WebApr 6, 2024 · According to 14 stock analysts, the average 12-month stock price forecast for CMPX stock is $ 9.37 , which predicts an increase of 200.32%. The lowest target is $ 8.08 and the highest is $ 11.55. On average, analysts rate CMPX stock as a buy. Analyst Consensus: Buy Analyst Ratings WebCompass Therapeutics Inc. analyst estimates, including CMPX earnings per share estimates and analyst recommendations.
WebApr 11, 2024 · Get a real-time Compass Therapeutics, Inc. (CMPX) stock price quote with breaking news, financials, statistics, charts and more. ... Analyst Forecast. According to … WebFind the latest Compass Therapeutics, Inc. CMPX analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. ... CMPX Compass …
WebCompass Therapeutics Inc. CMPX (U.S.: Nasdaq) View All companies AT CLOSE 4:00 PM EST 02/27/23 $3.93 USD 0.12 3.15% AFTER HOURS 7:55 PM EST 02/27/23 $3.99 … WebApr 6, 2024 · View Compass Therapeutics, Inc CMPX investment & stock information. Get the latest Compass Therapeutics, Inc CMPX detailed stock quotes, stock data, Real …
WebApr 12, 2024 · Simply Wall St. Published April 12, 2024. Source: Shutterstock. When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 16x, you may consider Enact Holdings, Inc. ( NASDAQ:ACT) as a highly attractive investment with its 5.5x P/E ratio. Nonetheless, we'd need to dig a little deeper to …
WebSee Compass Therapeutics, Inc. (CMPX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. double glazing spare parts ukWebApr 13, 2024 · To get a sense of who is truly in control of Compass Therapeutics, Inc. (NASDAQ:CMPX), it is important to understand the ownership structure of the business. The group holding the most number of ... double glazing standard nzWebThe latest price target for . Compass Therapeutics (NASDAQ: CMPX) was reported by HC Wainwright & Co. on Thursday, March 16, 2024.The analyst firm set a price target for … double glazing spacer bar sizesWebApr 10, 2024 · Compass Therapeutics Inc. (NASDAQ:CMPX)’s beta value is currently sitting at 0, while the Average True Range indicator is currently displaying 0.20. With analysts defining $8.00-$11.00 as the low and high price targets, we arrive at a consensus price target of $9.19 for the trailing 12-month period. rack mount ups 1u sizeWebPrice target 9.19 0.00 0.00% The 7 analysts offering 1 year price forecasts for CMPX have a max estimate of — and a min estimate of —. Analyst rating Based on 8 analysts giving stock ratings to CMPX in the past 3 months. Neutral Sell Buy Strong sell Strong buy Strong buy Strong buy 0 Buy 0 Hold 0 Sell 0 Strong sell 0 EPS Annual Quarterly 0 rack mezzanine platformWebJan 26, 2024 · SVB Securities analyst Andrew Berens maintained a Buy rating on Compass Therapeutics (CMPX - Research Report) yesterday. The company's shares closed yesterday at $4.21.According to TipRanks, Berens is a 4-star analyst with an average return of 4.1% and a 47.71% success rate. rack na logisticaWebApr 6, 2024 · Detailed statistics for Compass Therapeutics, Inc. (CMPX) stock, including valuation metrics, financial numbers, share information and more. ... Analyst Forecast. … rack nameka